No Data
No Data
MiMedx Group, Inc.'s (NASDAQ:MDXG) Share Price Is Matching Sentiment Around Its Revenues
With a price-to-sales (or "P/S") ratio of 3.1x MiMedx Group, Inc. (NASDAQ:MDXG) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in the United
Analyst Bullish On MiMedx's Rapid Growth In $4B Woundcare Market With Innovative Skin Substitutes
Cantor Fitzgerald has initiated coverage on MiMedx Group Inc. (NASDAQ:MDXG), a provider of a product portfolio for applications in wound care, burn, and surgical recovery.The analyst notes that MIMEDX
Cantor Starts MiMedx at Overweight, Cites Valuation, Product Offerings
MiMedx Group Initiated at Overweight by Cantor Fitzgerald
MiMedx Group Initiated at Overweight by Cantor Fitzgerald
Cantor Fitzgerald Initiates MiMedx(MDXG.US) With Buy Rating, Announces Target Price $11
Cantor Fitzgerald analyst Ross Osborn initiates coverage on $MiMedx(MDXG.US)$ with a buy rating, and sets the target price at $11.According to TipRanks data, the analyst has a success rate of 18.1% an
Express News | MiMedx Announces the Appointment of Kim Moller to Chief Commercial Officer